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ta.2012.0Abstract Objective: To determine the effectiveness of topical application of platelet -rich plasma
(PRP) following submucous diathermy (SMD) in promoting the normal ciliary function and
improving the healing of nasal turbinate.
Patients and methods: This is a prospective randomized single blinded study done on 60 patients
with inferior turbinate hypertrophy (with no or minimal septal deviation). They were divided into 2
groups, study group A consisting of 30 patients who were candidates for bilateral SMD and then
PRP was applied; and control group B (30 patients) who were candidates for the same surgery but
saline was used instead of PRP. Both groups were followed up after 3 days postoperative, then at
1 week, 2 weeks, one month and 2 months consecutively. Nasal mucociliary clearance (NMC)
before surgery was assessed (baseline) and was compared to the NMC in the two-week and two-
month post operative periods.
Results: Nasal mucociliary clearance was improved in both patient groups but it was statistically
more signiﬁcant in group A (with PRP).
Conclusion: Platelet-rich plasma has an effective role after submucous diathermy in improve-
ment of nasal mucociliary clearance and decreased incidence of bleeding and crust formation.
ª 2012 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
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Nasal obstruction is common in the adult population and may
affect the patients’ health via prolonged respiratory infections,m (A. Hussein).
yptian Society of Ear, Nose,
g by Elsevier
ar, Nose, Throat and Allied Scien
3.003secondary sinus involvement, diminution of the sense of smell,
and sleep disorders.1–4 Etiology of chronic nasal obstruction
due to hypertrophy of inferior turbinate is usually perennial
allergic rhinitis and vasomotor rhinitis; the turbinate enlarge-
ment of these patients is usually bilateral and is caused by
thickening of the mucosa without hypertrophy of the underly-
ing bony structure.5 Medical treatment including antihista-
mine, topical and systemic steroids and allergen avoidance
are used ﬁrst but if these measures fail, surgery is advised
including resection of the entire turbinate,6,7 cryosurgery,8,9
laser turbinectomy, sub mucosal diathermy (SMD)10 and
recently radiofrequency coblation technique.11ces. Production and hosting by Elsevier B.V. All rights reserved.
72 A.H. Salaheldin, A. HusseinThe procedure of SMD was reported since 1907.12 The
coagulative current in SMD is believed to do the tissue necrosis
and ﬁbrosis causing shrinkage of the soft tissue of the turbi-
nate.13,14 Although SMD is widely used and preferred by many
surgeons, it is not free from complications which include adhe-
sion, tissue sloughing, excessive scaring and bleeding.
The use of platelet-rich plasma in oral surgery was intro-
duced in 1997 by Whitman et al.15and since that time different
researches were done in oral surgery with different results
about the effect of PRP on healing. Sanchez et al. 2003 con-
cluded that there is no scientiﬁc evidence to support the use
of PRP in combination with bone graft during augmentation
procedures.16 On the other hand; Marx 2004 supported the
use of PRP because it enhances soft tissue, mucosal and skin
healing.17 PRP is tested in many different clinical situations
to improve healing; here it is tested to see the effect on the heal-
ing post SMD as measured by NMC and the possibility to
minimize the post-operative complication of SMD.2. Patients and methods
This study is a prospective single blinded randomized study
done on 60 patients (36 males and 24 females), between March
2009 to March 2011. This study has been done after getting an
approval from the local ethics committee and informed con-
sents taken from the patients.
Age of the patients ranged from 18 to 50 with the mean
31.5. All the patients had inferior turbinate hypertrophy (with
no or minimal septal deviation) causing chronic nasal obstruc-
tion and did not respond to medical treatment. Patients were
diagnosed and collected in the outpatient clinic based on his-
tory, anterior rhinoscopy and rigid endoscopy. The following
patients were excluded from the study: (1) patients with any
bleeding disorder; (2) residence outside the city, incomplete ad-
dress, or patients who were unable to come for follow up; (3)
patients with associated marked septal deviation, nasal polyps,
tumors or sinusitis; (4) patients with previous turbinate surgery
and (5) patients with diabetes mellitus, uncontrolled hyperten-
sion. Furthermore, patients with genetic disorder accompanied
by ciliary dysfunction were also excluded.
Patients were divided into 2 groups, group A containing 30
patients and group B with the same number of patients. In the
ﬁrst group, SMD of the inferior turbinate was done followed by
application of PRP (test group), whereas in the second group
SMD was done without application of PRP and saline was ap-
plied (control group). Surgery was done under general anesthe-
sia and each patient was randomized (randomization done
using the sealed envelope technique). The anesthesia was stan-
dardized (same technique and same protocol) and no pre- med-
ications were given. SMD was done using system 5000, 40
joules applied to a partially insulated gauge 18 cannula, the
non insulated part was inserted submucosally into the inferior
turbinate for about 1.5 cm from the anterior end on two succes-
sive applications, one on the medial portion and the other on
the inferior portion, the diathermy circuit is closed while the
electrode is gradually withdrawn so that a submucosal linear
burn results with minimal injury to the mucosal surface and
avoid buttonholing of the mucosa. Postoperative nasal pack
was not needed after surgery. A broad spectrum prophylactic
postoperative antibiotic was prescribed to the patients, butantihistamines, decongestants, analgesics, or nasal sprays were
not given. All cases were discharged in the same day.
Follow up visits were scheduled after 3 days, 7 days,
2 weeks, 1 month, and 2 months post-operative. Data were
collected from the preoperative period and in each postopera-
tive visit then statistical analysis was done.
2.1. Technique of PRP preparation
Twenty-ﬁve milliliters of autologous blood drawn from the pa-
tient during anesthesia induction were processed during SMD
using a laboratory centrifuge (Heraeus labofuge 200, Ger-
many). The blood was centrifuged on two sessions, the ﬁrst
one is called soft spin and allows the blood to be separated into
3 layers namely: bottom-most RBC layer, top-most acellular
plasma layer which is called PPP (platelet-poor plasma) and
the intermediate PRP layer which is called the Buffy coat.
The PPP and PRP and some RBCs were transferred into an-
other tube and underwent a second centrifugation called hard
spin which is longer and faster than the ﬁrst. This allows the
platelet to settle at the bottom with few RBCs.18,19 PRP was
then mixed with an equal amount of calciﬁed thrombin for
activation and then applied directly to one side of the nose
with syringe where it formed a matrix which looked like a
blood clot.
2.2. Measurement of mucociliary function
Nasal mucociliary clearance was assessed by using the saccha-
rin transit time (ST) test on the ﬁrst day of the study as a base-
line before SMD (patients with ST > 30 min were excluded)
and was done after 2 weeks and 2 months postoperative. The
patients were seated comfortably in the test room with con-
stant humidity and room temperature of 20–22 C for at least
20 min in order to keep them in a stable physiological and
environmental state while instructions were given prior to test-
ing. A 5 mg of saccharin particle was applied on the inferior
turbinate 1.5 cm from the nares under direct visualization.
After placement of saccharin, the patient was asked to refrain
from sneezing, snifﬁng or bending. The transit time was re-
corded from the placement of the saccharin on the inferior tur-
binate until the patient reported a sweet taste to the nearest
minute. Thirty minutes was set as the upper limit of the normal
ST range.20
3. Results
Among the 60 patients included (36 males and 24 females), the
age ranged between 18 and 52 years with a mean age of
31.5 years.
There were no postoperative infection, nor adhesions .Crust
formation and mild bleeding were lesser in group A (2/30,
6.6%) than in group B (9/30, 30%). A transient worsening
of nasal blockage was reported by 3 patients (10%) in group
A and 6 patients (20%) in group B. A minimal postoperative
pain was noted by 4 patients (13%) in group A and 6 patients
(20%) in group B within the ﬁrst 3 postoperative days. There
was no statistical difference in mucociliary clearance between
group 1 and group 2 before the operation as p value was
0.36 (Table 1).
Table 1 Statistical difference in mucociliary clearance
between group A and group B before the operation using
independent sample T test.
Group N Mean Std.
deviation
Mean
diﬀerence
T P value
A 30 15.97 4.98 1.17 0.92 0.36
B 30 17.13 4.84
Table 2 Statistical difference in nasal mucociliary clearance
before and after intervention in group A.
Time N Mean Std. deviation F P value
Before operation 30 15.97 4.98 5.97 0.004*
2 weeks 30 12.77 4.72
2 months 30 11.97 4.53
* Means signiﬁcant P< 0.05.
Table 4 Statistical difference in nasal mucociliary clearance
before and after intervention in group B.
Time N Mean Std. Deviation F P value
Before operation 30 17.13 4.84 4.17 0.02*
2 weeks 30 14.73 4.28
2 months 30 13.87 4.47
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15.97 ± 4.98SD before the operation, at 2 weeks and 2 months
postoperatively, nasal mucociliary clearance mean was
12.77 ± 4.72 and 11.97 ± 4.53 respectively, the p value in this
group was highly signiﬁcant 0.004 (Table 2). In group B, pre-
operative nasal mucociliary clearance mean was 17.13 ± 4.84
and in 2 weeks and 2 months after operation was
14.73 ± 4.28 and 13.87 ± 4.47 respectively and the p value
was less signiﬁcant (0.02) than in group A (Table 4). The post-
operative improvement of NMC in group A and group B pa-
tients at 2 months was greater than at 2 weeks as p value was
more signiﬁcant (Tables 3 and 5).
4. Discussion
Nasal obstruction is a common presenting symptom in otolar-
yngology. Most patients have either septal deviation or hyper-
trophic inferior turbinate. The treatment of hypertrophic
inferior turbinate offers a wide range of surgical methods.
However, early complications after surgical interference
including bleeding, adhesion, and persistent nasal obstruction
(due to edema and crust formation) remain as problems which
lead to the search for minimal invasive surgeries.21 Also, con-
troversy remains in the appropriate surgical treatment of the
inferior turbinate hypertrophy because the hypertrophy tends
to recur after most treatments.22 Surgical treatment for inferior
turbinate hypertrophy was based on the assumption that an in-
crease in nasal airway volumes will lead to a better functional
nasal airﬂow and improvement of the symptoms. This is notTable 3 Exact place of statistically signiﬁcant difference of nasal mu
statistical difference) test in group A.
Time (Compared group) Mean diﬀerenc
Before operation 2 weeks 3.20
2 months 4.00
2 weeks 2 months 0.8
* Means signiﬁcant P< 0.05.completely true, because an over aggressive approach,
although this allows to completely solve the ventilation prob-
lem, there is interference with the nasal physiology in a signif-
icant way, so a wider nasal cavity does not necessarily mean
that the nose functions are better.23 It was noted that a huge
postoperative increase in nasal airﬂow corresponds to a de-
crease in the humidifying activity of the nasal mucosa with
an excessive drying of nasal secretions and consequent crust
formation. Moreover, the dramatic improvement in nasal air-
ﬂow following complete resection of the inferior turbinate is
accompanied by a decrease in efﬁciency of the mucociliary
transport and by a reduction in secretory IgA production.24
Successful surgical treatment of inferior turbinate hypertrophy
requires reduction of tissue volume with preservation of muco-
ciliary function. If little tissue is removed, the obstruction per-
sists. If mucociliary function is impaired, patients report
crusting.11
This study was conducted to determine if topical applica-
tion of platelet-rich plasma (PRP) after submucous diathermy
(SMD) will improve healing and normal ciliary function of na-
sal turbinate. Platelet-rich plasma contains multiple growth
and healing factors like platelet derived growth factor, trans-
forming growth factor and vascular endothelial growth factor.
The release of these factors is triggered by the activation of
platelets which can be initiated by a variety of substance or
stimuli such as thrombin, calcium chloride, collagen or adeno-
sine 5c-diphosphate; in addition to these growth factors PRP
contains ﬁbrinogen and a number of adhesive glycoprotein
that support cell migration.10
In this study, there was no statistical difference in mucocil-
iary clearance between group A and group B before the oper-
ation as p value was 0.36 (Table 1). It means that both groups
were randomizely selected and there was no statistical bias
which allows to compare mucociliary clearance postopera-
tively in both groups. Crust formation and mild bleeding were
lesser in group A (2/30, 6.6%) than in group B (9/30, 30%).
This raised the importance of PRP in decreasing crust forma-
tion and bleeding after SMD.
It was found in this study that mucociliary clearance in
group A patients was improved postoperatively and this
improvement increased at 2 months postoperative (p valuecociliary clearance before and after intervention using LSD (least
e P value 95% Conﬁdence interval
Lower bound Upper bound
.011* 0.76 5.64
.002* 1.56 6.44
0.52 1.64 3.24
Table 5 Exact place of statistically signiﬁcant difference of nasal mucociliary clearance before and after intervention using LSD (least
statistical difference) test in group A.
Time (Compared group) Mean diﬀerence P value 95% Conﬁdence interval
Lower bound Upper bound
Before operation 2 weeks 2.4 0.04* 0.07 4.73
2 months 3.27 0.01* 0.94 5.60
2 weeks 2 months 0.87 0.46 1.46 3.20
* Means signiﬁcant P< 0.05.
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Similarly, the mucociliary clearance improvement in group B
patients was more at 2 months (p value was 0.04 at 2 weeks
and 0.01 at 2 months) (Table 5). The improvement of mucocil-
iary clearance in group A (p value 0.004) was more compared
to group B (p value 0.02). The improvement in NMC was more
at 2 months postoperative because of less crustation and more
healing of mucosa at that time. From the previous ﬁndings, it
is concluded that SMD surgery leads to improvement in muco-
ciliary clearance especially after 2 months and this improve-
ment is increased if PRP is added during surgery.
Dale H. demonstrated that there are no beneﬁts in the
application of PRP after endoscopic sinus surgery and the
study was terminated early after 13 operations.25 In the study
of Jakse et al. on the effects of PRP on bone regeneration after
sinus lifting, they found a 3–4% increase in bone generation
with PRP, the difference was not statistically signiﬁcant – the
regenerative capacity of PRP was described as being of ‘‘quite
low potency’’.26 These previous research studies implied no
signiﬁcant effect in the application of PRP after surgery, this
may be because the surface area needed for healing is large
and cannot be covered all with PRP; this is because with
current harvesting techniques, 20 ml of a patient’s blood yields
only 2–3 ml of PRP.
In the present study, the topical application of PRP was sig-
niﬁcant in the improvement of NMC because the surface area
needed for healing is not so large and also, there is less mucosal
injury with SMD. Erkilet et al. suggested that platelet-rich
plasma is effective in accelerating tympanic membrane perfo-
ration healing in rats, and that it may be effective in human
subjects, particularly as it is an autologous material.27 The idea
in Erkilet et al. study is similar to the present study in terms of
the small surface area needed for healing. Also, Man et al. de-
scribed the beneﬁts of the use of PRP in cosmetic surgery.28
Also; Adler and Kent reported the advantage of using PRP
in face-lifts.29 Finally, Abuzeni and Alexander reported the
beneﬁts of PRP in autologous fat transfer in cosmetic
surgery.30
This study was done on 60 patients, only 30 of them with
added PRP. Further studies are needed on larger numbers of
patients with a longer period of follow up to evaluate the effect
of adding PRP on nasal ciliary functions and healing of nasal
mucosa after various nasal surgeries.5. Conclusion
Submucous diathermy of inferior turbinate leads to improve-
ment in nasal mucociliary clearance especially after 2 months.If platelet rich plasma is added at the end of submucous dia-
thermy surgery, there will be a greater improvement of nasal
mucociliary clearance with less bleeding and crust formation.
Platelet rich plasma is simple and easy to be prepared with
no reported side effects.
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